Monotherapy or in combination w/ other medicinal products for adults w/ type 2 DM to improve glycemic control as an adjunct to diet & exercise. Adjunct to standard therapy to reduce the risk of sustained eGFR decline, end-stage kidney disease & CV death in adults w/ CKD at risk of progression.